Envestnet Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
|
|||||
|
2025
Q1 | $922K | Buy |
|
|||||
|
2024
Q4 | $697K | Buy |
|
|||||
|
2024
Q3 | $935K | Buy |
|
|||||
|
2024
Q2 | $660K | Buy |
|
|||||
|
2024
Q1 | $661K | Sell |
|
|||||
|
2023
Q4 | $615K | Buy |
|
|||||
|
2023
Q3 | $401K | Buy |
|
|||||
|
2023
Q2 | $340K | Sell |
|
|||||
|
2023
Q1 | $409K | Sell |
|
|||||
|
2022
Q4 | $410K | Sell |
|
|||||
|
2022
Q3 | $284K | Buy |
|
|||||
|
2022
Q2 | $285K | Buy |
|
|||||
|
2022
Q1 | $326K | Buy |
|
|||||
|
2021
Q4 | $242K | Sell |
|
|||||
|
2021
Q3 | $342K | Buy |
|
|||||
|
2021
Q2 | $347K | Buy |
|
|||||
|
2021
Q1 | $333K | Sell |
|
|||||
|
2020
Q4 | $287K | Buy |
|
|||||
|
2020
Q3 | $230K | Buy |
|
|||||
|
2020
Q2 | $190K | Buy |
|
|||||
|
2020
Q1 | $167K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1K | Hold |
|
|||||
|
2016
Q4 | $1K | Buy |
|